Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Stock Exchange of Hong Kong  >  Genscript Biotech Corp    1548   KYG3825B1059

GENSCRIPT BIOTECH CORP

(1548)
My previous session
Most popular
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Stock Exchange Of Hong Ko…
02/18/2019 02/19/2019 02/20/2019 02/21/2019 02/22/2019 Date
14.5 13.84 13.78 14.08 14.2 Last
6068000 6148000 5503472 5346000 4850100 Volume
+0.83% -4.55% -0.43% +2.18% +0.85% Change
Financials (HKD)
Sales 2018 1 689 M
EBIT 2018 262 M
Net income 2018 261 M
Finance 2018 196 M
Yield 2018 -
Sales 2019 2 045 M
EBIT 2019 319 M
Net income 2019 315 M
Debt 2019 173 M
Yield 2019 -
P/E ratio 2018 94,35
P/E ratio 2019 81,52
EV / Sales2018 15,3x
EV / Sales2019 12,8x
Capitalization 26 091 M
More Financials
Company
Genscript Biotech Corporation is a Hong Kong-based investment holding company principally engaged in life science research and related businesses. The Company operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and... 
More about the company
Surperformance© ratings of Genscript Biotech Corp
Trading Rating : Investor Rating :
More Ratings
Latest news on GENSCRIPT BIOTECH CORP
02/04China Resources, Charoen Pokphand launch $300M life science fund
AQ
2018Amgen antibody shows promise in myeloma trial, gets FDA fast track
RE
2018GENSCRIPT BIOTECH : Bio buys back 500,000 shares
AQ
2018GENSCRIPT BIOTECH : Bio takes legal actions against Flaming Research
AQ
2018JOHNSON & JOHNSON : Short seller accuses GenScript of CAR T data fraud
AQ
2018GENSCRIPT BIOTECH : Stock of China's GenScript Plummets on Report Critical of Un..
DJ
2018GENSCRIPT BIOTECH : Bio inks cancer drug's license & development deal
AQ
2018GENSCRIPT BIOTECH : Bio 1H net up 3.6% to US$15.5m; no div
AQ
2018GENSCRIPT BIOTECH : Bio to invest in bio-fermentation products biz
AQ
2018JOHNSON & JOHNSON : J&J Bets on Chinese Startup That Uses Llama DNA to Fight Can..
DJ
More news
Sector news : Bio Diagnostics & Testing
02/20GLOBAL MARKETS LIVE : Nissan, Lockheed Martin, UBS, Sainsbury...
02/12MARKET SNAPSHOT: Stocks Close At 2019 High On Tentative Deal To Avert Governm..
DJ
02/11Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price
DJ
02/11Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
RE
02/06REGENERON PHARMACEUTICALS : 4Q Profit Rises
DJ
More sector news : Bio Diagnostics & Testing
Chart GENSCRIPT BIOTECH CORP
Duration : Period :
Genscript Biotech Corp Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENSCRIPT BIOTECH CORP
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 35,3  HKD
Spread / Average Target 148%
EPS Revisions
Managers
NameTitle
Fang Liang Zhang Chairman & Chief Executive Officer
Ye Wang President, COO & Executive Director
Jian Ge Meng Executive Director & VP-Investor Relations
Lu Quan Wang Non-Executive Director
Yue Xin Pan Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENSCRIPT BIOTECH CORP35.24%3 325
MIRACA HOLDINGS INC.21.55%1 532
INVITAE CORP--.--%1 434
CAREDX INC17.74%1 220
IOVANCE BIOTHERAPEUTICS INC10.85%1 208
BEIJING STRONG BIOTECHNOLOGIES INC--.--%910